Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial

Last updated: November 19, 2024
Sponsor: McMaster University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Usual Care

Sputum-guided management and comprehensive care management

Clinical Study ID

NCT04890938
13532
  • Ages > 40
  • All Genders

Study Summary

Chronic obstructive pulmonary disease (COPD) is a lung condition affecting 1 in 6 Canadians and does not have a cure. Flare-ups of COPD are the most common reason someone goes to hospital in Canada. This is made worse because within 30-days of having a flare-up, 1 in 5 patients will come back to hospital for the same problem.

Flare-ups of COPD often have many causes and these are different person to person. Sometimes it is related to behaviours such as smoking or not using medicines properly. Other times, it is from lung inflammation. Education programs that help people learn about their disease and maintain healthy behaviours, and using phlegm to decide on which medicines will be useful, have been studied separately and appear to work, but many people still have flare-ups. To help fix this problem, we need to look carefully at each patient, to make sure they are on the right medicine but also have the right behaviours and support to benefit from medical care.

The goal of this project is to see if patients who are taught the right behaviours and have their lung inflammation controlled with the right medicines will have fewer COPD flare-ups than those who get normal care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • >=2 exacerbations of COPD in the last 12-months, FEV1/FVC<0.7 or radiologicemphysema, with a >-10 pack-year smoking history

Exclusion

Exclusion Criteria:

  • severe mental illness not controlled by medication or life-expectancy less than 6-months

Study Design

Total Participants: 128
Treatment Group(s): 2
Primary Treatment: Usual Care
Phase:
Study Start date:
May 27, 2022
Estimated Completion Date:
August 31, 2025

Study Description

STRIVE is a randomized-controlled trial comparing a two-pronged intervention, including sputum-biomarker-directed treatment of airway inflammation, and comprehensive care management, to usual care, for COPD patients with frequent exacerbation from two sites.

The intervention consists of 6-months of comprehensive care management (CCM) and sputum biomarker-directed treatment of airway inflammation, including hospital and clinic visits. Clinic visits will occur at 2, 6 and 16 weeks after hospital discharge. For the intervention group, the key elements of CCM will be provided, including case management, self-management education, and coordination of community/hospital resources (1). Spontaneous sputum biomarkers will be used to direct therapy at the time of AECOPD and during clinic visits after hospital discharge.

Connect with a study center

  • Hamilton General Hospital

    Hamilton, Ontario L8L 2X2
    Canada

    Site Not Available

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario L8N 4A6
    Canada

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.